Abstract:Recent studies have highlighted the pivotal roles of circular RNAs (circRNAs) in cardiovascular diseases. Through high-throughput circRNA sequencing of both normal myocardial tissues and hypertrophic patients, we unveiled 32,034 previously undiscovered circRNAs with distinct cardiac expression patterns. Notably, circITGa9, a circRNA derived from integrin-α9, exhibited substantial up-regulation in cardiac hypertrophy patients. This elevation was validated across extensive sample pools from cardiac patients and donors. In vivo experiments revealed heightened cardiac fibrosis in mice subjected to transverse aortic constriction (TAC) after circITGa9 injection. We identified circITGa9 binding proteins through circRNA precipitation followed by liquid chromatography tandem-mass spectrometry. Furthermore, circRNA pull-down/precipitation assays demonstrated that increased circITGa9 expression facilitated binding with tropomyosin 3 (TPM3). Specific binding sites between circITGa9 and TPM3 were identified through computational algorithms and further validated by site-directed mutagenesis. We further showed that circITGa9 induced actin polymerization, characteristic of tissue fibrosis. Finally, we developed approaches that improved cardiac function and decreased fibrosis by delivering small interfering RNA targeting circITGa9 or blocking oligo inhibiting the interaction of circITGa9 and TPM3 into TAC mice, which is amenable for further preclinical and translational development. We conclude that elevated circITGa9 levels drive cardiac remodeling and fibrosis. By pinpointing circITGa9 as a therapeutic target, we open doors to innovative interventions for mitigating cardiac remodeling and fibrosis.

Circular RNAs As Novel Regulators, Biomarkers and Potential Therapies in Fibrosis

Circular RNAs in Organ Fibrosis

Circular RNA Circube2k Promotes Hepatic Fibrosis Via Sponging Mir‐149‐5p/tgf‐β2 Axis

CircRNAs: versatile players and new targets in organ fibrosis

Role of Circular RNAs in Pulmonary Fibrosis

CircRNAs: Decrypting the novel targets of fibrosis and aging

Insights into the Role of Circular RNA in Macrophage Activation and Fibrosis Disease

Long Noncoding RNA: a New Contributor and Potential Therapeutic Target in Fibrosis

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis

Circular RNAs: a Novel Tool in the Development of Digestive System Biomarker

Noncoding RNA network crosstalk in organ fibrosis

LncRNA: Shedding Light on Mechanisms and Opportunities in Fibrosis and Aging

Noncoding RNAs As Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: the Path from Bench to Bedside.

Biogenesis and Function of circRNAs in Pulmonary Fibrosis

Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases

Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis

Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease.

Circular RNA As an Epigenetic Regulator in Chronic Liver Diseases

Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433

A Novel Circular RNA circITGa9 Predominantly Generated in Human Heart Disease Induces Cardiac Remodeling and Fibrosis

Circular RNAs and their roles in idiopathic pulmonary fibrosis